(Rac)-Mirabegron D5 is the penta-deuterated form (in the terminal phenyl ring) of (Rac)-Mirabegron (YM-178;
YM178; Myrbetriq; Betanis; Betmiga) which is a β3-adrenoceptor agonist and approved drug for the treatment of overactive bladder.